Loraz and Blood creatine phosphokinase abnormal - a phase IV clinical study of FDA data

Summary:

Blood creatine phosphokinase abnormal is reported as a side effect among people who take Loraz (lorazepam), especially for people who are female, 10-19 old, have been taking the drug for < 1 month also take Acetaminophen, and have Oesophageal squamous cell carcinoma.

The phase IV clinical study analyzes which people have Blood creatine phosphokinase abnormal when taking Loraz. It is created by eHealthMe based on reports of 161,700 people who have side effects when taking Loraz from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.

What is Blood creatine phosphokinase abnormal?

Blood creatine phosphokinase abnormal is found to be associated with 89 drugs and 246 conditions by eHealthMe. Check the latest studies of Blood creatine phosphokinase abnormal.

On Jul, 15, 2026

161,700 people reported to have side effects when taking Loraz.
Among them, 19 people (0.01%) have Blood creatine phosphokinase abnormal.

Could Loraz cause Blood creatine phosphokinase abnormal?

Among these 19 people:

How long have people been on Loraz when they have Blood creatine phosphokinase abnormal? *

What is the gender of people who have Blood creatine phosphokinase abnormal when taking Loraz? *

female: 52.63 %
male: 47.37 %

What is the age of people who have Blood creatine phosphokinase abnormal when taking Loraz? *

What are other drugs people take besides Loraz? *

Acetaminophen: 4 people, 21.05%
Cisplatin: 3 people, 15.79%
Diovan: 3 people, 15.79%
Taxol: 3 people, 15.79%
Fentanyl Transdermal System: 3 people, 15.79%
Omeprazole: 3 people, 15.79%
Xeljanz: 2 people, 10.53%
Epinephrine: 2 people, 10.53%
Ibuprofen: 2 people, 10.53%
Heparin: 2 people, 10.53%

What are other side effects people have besides Blood creatine phosphokinase abnormal? *

Hypotension (abnormally low blood pressure): 9 people, 47.37%
Intentional Self-Injury: 7 people, 36.84%
Diarrhea: 4 people, 21.05%
High Blood Pressure: 4 people, 21.05%
White Blood Cell Count Decreased: 4 people, 21.05%
Swallowing Difficulty: 3 people, 15.79%
Blood Sodium Decreased: 3 people, 15.79%
Lymphopenia (an abnormally low level of lymphocytes in the blood): 3 people, 15.79%
Thrombocytopenia (decrease of platelets in blood): 3 people, 15.79%
Mucosal Inflammation (infection of mucous membrane): 3 people, 15.79%

What are the existing conditions these people have? *

Oesophageal Squamous Cell Carcinoma (cancer that begins in flat cells lining the oesophagus): 3 people, 15.79%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 10.53%
Polymyositis (inflammatory muscle disease that causes weakness of the skeletal muscles): 2 people, 10.53%
Pain: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and have Blood creatine phosphokinase abnormal?

- Check whether Blood creatine phosphokinase abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Loraz:

Loraz (165,694 reports)

Browse all side effects of Loraz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blood creatine phosphokinase abnormal:

Blood creatine phosphokinase abnormal (89 drugs)

Browse all the conditions that are associated with Blood creatine phosphokinase abnormal:

Blood creatine phosphokinase abnormal (246 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam (the active ingredients of Loraz) and Loraz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.